Gabapentin

CHEMBL940 Phase 4 Onaylandı Small molecule
Half-Life
5-7 hours
Bioavailability
Protein Binding
Molecular Weight
171.2 g/mol
LogP
-1.1
Phase
4

Originally developed as an anticonvulsant, gabapentin found its widest use in treating nerve pain. It binds the alpha-2-delta subunit of voltage-gated calcium channels, reducing calcium entry at nerve terminals and thereby dampening the release of excitatory signals that carry abnormal or painful impulses. This action underlies its use in epilepsy, postherpetic neuralgia, and a range of other neuropathic pain conditions. A small molecule (C9H17NO2) structurally related to the neurotransmitter GABA, though it does not act directly on GABA receptors, it has a half-life of about 5 to 7 hours and is eliminated unchanged by the kidneys. Its renal clearance shapes dosing in people with reduced kidney function. Gabapentin is an approved medicine spanning seizure control and chronic pain.

This medication was originally developed as an anticonvulsant but is also widely used to treat nerve pain by modulating calcium channels in nerve cells to reduce abnormal electrical activity. It is prescribed for epilepsy, postherpetic neuralgia, and various other neuropathic pain conditions.

Moleküler Ağırlık

171,2370 g/mol

LogP

-1,10

TPSA

63,30 Ų

Lipinski RO5

Geçer

Terapötik Alanlar

İlaç Sınıfları

Etki Mekanizması

Binds alpha-2-delta subunit of voltage-gated calcium channels.

Pharmacokinetics (PK)

Half-Life 5-7 hours

Pharmacodynamics (PD)

Mekanizma

Binds alpha-2-delta subunit of voltage-gated calcium channels.

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

NCC1(CC(=O)O)CCCCC1

InChI

InChI=1S/C9H17NO2/c10-7-9(6-8(11)12)4-2-1-3-5-9/h1-7,10H2,(H,11,12)

Molecular Formula

C9H17NO2

HBD / HBA

2 / 3

Döndürülebilir Bağlar

3

Ağır Atomlar

12

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This medication was originally developed as an anticonvulsant but is also widely used to treat nerve pain by modulating calcium channels in nerve cells to reduce abnormal electrical activity. It is prescribed for epilepsy, postherpetic neuralgia, and various other neuropathic pain conditions.

Binds alpha-2-delta subunit of voltage-gated calcium channels.

Key pharmacokinetic parameters for Gabapentin: Half-life: 5-7 hours.

Yes, Gabapentin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

Related Drugs

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL940. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3446. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.